Premium
COUNSELLING PATIENTS ON ORAL ANTICOAGULANT THERAPY–A PILOT STUDY
Author(s) -
Refsum N.
Publication year - 1987
Publication title -
journal of clinical pharmacy and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.622
H-Index - 73
eISSN - 1365-2710
pISSN - 0269-4727
DOI - 10.1111/j.1365-2710.1987.tb00523.x
Subject(s) - medicine , concomitant , oral anticoagulant , anticoagulant therapy , pharmacist , emergency medicine , anticoagulant , drug , intensive care medicine , physical therapy , warfarin , surgery , family medicine , pharmacy , psychiatry , atrial fibrillation
SUMMARY On a 38‐bed General Medicine Unit, 12 of 15 patients discharged on oral anticoagulant therapy required counselling during a 7‐week period. The study indicates that all patients who were responsible for administration of their own drugs after discharge, needed counselling, whether they received anticoagulants prior to admission or not. On average, one hour per week was required to identify the patients, and one hour per patient was spent on counselling. Counselling selected patients provides the pharmacist with a defined role in relation to each patient. It can easily be expanded gradually to include other patients and/or by concomitant monitoring drug therapy.